BlackRock Advisors’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
PAI
BFA
EWM
BIT
BlackRock Advisors's ABMD Position: Q4 2016 in Review
BlackRock Advisors reduced its Abiomed Inc (ABMD) stake by 35% in Q4 2016, selling an estimated $1.44M and leaving 23,585 shares worth $2.66M. The position accounts for ﹤0.01% of the portfolio, ranked #1386.
BlackRock Advisors first reported a position in ABMD in Q2 2013 and has held it in 15 quarters since. The position peaked at $4.63M in Q3 2016. 297 funds tracked by Wall St. Rank hold ABMD as of Q4 2016.
- BlackRock Advisors held 23,585 shares of Abiomed Inc worth $2.66M as of Q4 2016.
- BlackRock Advisors sold 12,437 Abiomed Inc shares in Q4 2016, an estimated $1.44M.
- Abiomed Inc made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #1386 holding.
- BlackRock Advisors first reported a position in Abiomed Inc in Q2 2013 and has held it in 15 quarters since.
- BlackRock Advisors's Abiomed Inc position peaked at $4.63M in Q3 2016.
- 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2016.
Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.